Effect of CYP2C9/CYP2C19 Polymorphism on Pharmacokinetics of Phenobarbital in Korean Neonatal Seizure Patients.
NCT01224457
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
52
Enrollment
OTHER
Sponsor class
Conditions
Neonatal Seizure
Interventions
DRUG:
Phenobarbital
Sponsor
Yonsei University